CN100475840C - Wasp antibiotic peptide and preparing method and use thereof - Google Patents

Wasp antibiotic peptide and preparing method and use thereof Download PDF

Info

Publication number
CN100475840C
CN100475840C CNB2005100106647A CN200510010664A CN100475840C CN 100475840 C CN100475840 C CN 100475840C CN B2005100106647 A CNB2005100106647 A CN B2005100106647A CN 200510010664 A CN200510010664 A CN 200510010664A CN 100475840 C CN100475840 C CN 100475840C
Authority
CN
China
Prior art keywords
wasp
bacterial peptide
hornet
chromatography
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100106647A
Other languages
Chinese (zh)
Other versions
CN1683399A (en
Inventor
赖仞
徐学清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Institute of Zoology of CAS
Original Assignee
Kunming Institute of Zoology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Institute of Zoology of CAS filed Critical Kunming Institute of Zoology of CAS
Priority to CNB2005100106647A priority Critical patent/CN100475840C/en
Publication of CN1683399A publication Critical patent/CN1683399A/en
Application granted granted Critical
Publication of CN100475840C publication Critical patent/CN100475840C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention belongs to the field of biomedicine technology. Wasp antibiotic peptide is a kind of single-stranded polypeptide separated from wasp venom and with molecular weight of 1316.6 dalton, isoelectric point of 8.59, and polypeptide whole sequence of NH2-IDWKGIAAMAKI-COOH. It is prepared through electrically stimulating wasp to collecting wasp venom, centrifuging to eliminate precipitate, freeze drying, chromatographic separation and purification in gel column, ion exchange column and reverse high pressure liquid phase chromatography. The wasp antibiotic peptide has powerful activity of inhibiting bacteria, fungi, viruses and tumor cell growth and the advantages of no hemolysis activity, etc. and may be used in preparing medicine for treating pathogeneic microbial infection disease and tumor.

Description

Hornet anti-bacterial peptide and its production and application
Technical field:
The present invention relates to a kind of hornet anti-bacterial peptide and its production and application, belong to field of biomedicine technology.
Background technology:
Since the discovery of penicillin makes people no longer at a loss what to do to all kinds of diseases that caused by cause pathogeny imcrobe infection, and developed a large amount of β-Nei Xiananleikangshengsus thus, the protection human health has been made a great contribution.But, constantly produce many new problems along with being extensive use of of above-mentioned " traditional microbiotic ".Cause the generation of drug resistance strain as life-time service.Sometimes even develop into some pathogenic bacterial infection and do not had medicine to be used for clinical treatment.So the development of antiseptic-germicide of new generation becomes the task of top priority.Recent discovers that peptide antibiotics has broad-spectrum antibacterial activity, has " traditional microbiotic " incomparable superiority simultaneously: can not induce the generation of drug resistance strain, promise to be antiseptic-germicide of new generation.
It is with a long history that bee product is widely used in medicine, takes root among the among the people and traditional medicine.It mainly contains: honey, beeswax, bee pollen, bee venom, propolis, royal jelly, queen bee nit, drone pupae, queen bee platform, honeycomb etc.Wherein bee venom is most widely used, and its composition is made up of polypeptide, enzyme, biogenic amine, carbohydrate and other materials.The pharmacological action that has been in the news has: close neural characteristic, antibacterial activity, cytotoxicity and all there is remarkable effect aspects such as internal secretion, cardiovascular systems, radioprotective, body's immunological function.
Early 1930s, taking-up bee venom from the honeybee that lives such as Germany is made formulations such as injection, ointment and is done clinical application, the fifties, melissotherapy was used widely in many hospitals of USSR (Union of Soviet Socialist Republics), and treatment hypertension, rheumatism, rheumatoid arthritis, lopsided spondylitis, peripheral nerve inflammation, muscle inflammation, neurodynia, migraine, peripheral blood vessel is atherosis etc. all obtained tangible curative effect.The Cha Lisimailazi of North America gathers the bee venom injection treatment multiple sclerosis that pure bee venom is made, and is evident in efficacy.But the bee venom mixture has many side effects and untoward reaction when being directly used in treatment, as: allergy appears in only a few patient, and untoward reactions such as proteinuria, kidney injury appear in small number of patients.Vespa magnifiac (Sonan). (Vespa magnifica Smith) is Vespidae Vespa member, mainly be distributed in China Sichuan, Yunnan, Tibet and Taiwan, it is one of characteristic resources animal of China, and by artificial breeding, in addition, the antimicrobial component of finding its venom does not after deliberation have shortcomings such as hemolytic activity and cytotoxicity.
The contriver searches for hornet anti-bacterial peptide complete sequence structure of the present invention and relatively finds no any identical polypeptide through albumen database.
Summary of the invention:
The object of the present invention is to provide a kind of new hornet anti-bacterial peptide and preparation method thereof and the application in pharmacy with wide spectrum antimicrobial (comprising gram-negative, positive bacteria, fungi, virus), anti-tumor activity.
In order to realize purpose of the present invention, the invention provides following technical scheme:
Hornet anti-bacterial peptide separates a kind of single chain polypeptide that obtains first for us from Chinese segmental appendage class animal wasp venom, molecular weight 1316.6 dalton, iso-electric point 8.59, the polypeptide total order is classified as: Isoleucine-aspartic acid-tryptophane-LYS-GLY-Isoleucine-Ala-Ala-methionine(Met)-L-Ala-Methionin-Isoleucine (NH 2-IDWKGIAAMAKI-COOH).
The preparation method of hornet anti-bacterial peptide: present method comprises the centrifugal removal precipitation of bee venom that the electricity irritation wasp is collected, and lyophilize is after gel filtration chromatography, ion-exchange chromatography and anti-phase high pressure liquid chromatography separation and purification; Wherein:
Gel filtration chromatography is: after being dissolved in pure water, the wasp venom lyophilized powder of collecting is splined on the SephadexG-50 gel-filtration column, and gel-filtration column length 1000mm, diameter 26mm uses 0.1M Na 2HPO 4-NaH 2PO 4The pH6.0 buffer solution elution is collected the III peak;
Ion-exchange chromatography is: the activeconstituents peak III that gel filtration chromatography obtains is splined on 0.1MNa 2HPO 4-NaH 2PO 4PH 6.0 damping fluid equilibrated CM Sephadex C-25 cationic exchange coloums, exchange column length 300mm, diameter 26mm is with the 0.1M Na that contains Nacl 2HPO 4-NaH 2PO 4PH 6.0 buffer solution for gradient elution are collected the V peak;
Anti-phase high pressure liquid chromatography is: the activeconstituents peak V that ion-exchange chromatography obtains is splined on through containing the ultrapure water equilibrated C18 reversed-phase column of 1 ‰ trifluoroacetic acids, column length 300mm, diameter 5mm, with the gradient elution of the fine damping fluid of the second that contains 1 ‰ trifluoroacetic acids from 15% to 65%, collection time is the peak at 45.4min place.
The present invention adopts the time-of-flight mass spectrometry (TOFMS) determining molecular weight, and iso-electric point is measured in isoelectrofocusing, and Protein Sequencer is measured the aminoacid sequence structure automatically.
Hornet anti-bacterial peptide is as the application of preparation cause pathogeny imcrobe infection treatment of diseases medicine and anti-tumor medicine.
The pharmacological results with hornet anti-bacterial peptide of the present invention illustrates drug action of the present invention and beneficial effect below:
1. the effect of hornet anti-bacterial peptide bacteria growing inhibiting
Anti-microbial activity detects and adopts cylinder plate method, and substratum is the plain agar substratum.Inject respectively substratum 20ml that heating dissolves in plate as bottom, make its even stand cloth at the bottom of ware, get an amount of heating of substratum after solidifying in addition and dissolve, in every ware, add the 5ml bacteria suspension respectively, shake up and make its even stand cloth on bottom, as the bacterium layer.After the cooling, put into 6 of disinfectant stainless steel cups in the plate moderate distance.First steel bowl adds the testing compound solution 0.1ml of 0.3mg/ml concentration, and all the other steel bowls adopt doubling dilution to add sample liquid, and the inhibition zone size is measured in 37 ℃ of cultivations behind the 24h.Inhibition zone 10mm above as minimal inhibitory concentration (minimalinhibitory concentration, MIC).Bacterial isolates derives from No.1 Hospital Attached to Kunming Medical College, this experiment do four parallel, get geometrical mean, result such as table 1.
The effect of table 1. hornet anti-bacterial peptide bacteria growing inhibiting
Figure C20051001066400051
By table 1 as seen, the pure product of wasp venom and hornet anti-bacterial peptide all have significant bacteria growing inhibiting effect.
2. hornet anti-bacterial peptide suppresses the effect of fungal growth
Anti-mycotic activity detects and adopts cylinder plate method, and substratum is improvement husky Bao Shi (Sabousand) substratum.Inject respectively substratum 20ml that heating dissolves in plate as bottom, make its even stand cloth at the bottom of ware, get an amount of heating of substratum after solidifying in addition and dissolve, in every ware, add the 5ml bacteria suspension respectively, shake up, make its even stand cloth on bottom, as the bacterium layer.After the cooling, put into 5 of disinfectant stainless steel cups in the plate moderate distance.First steel bowl adds the testing compound solution 0.1ml of 0.3mg/ml concentration, and all the other steel bowls adopt doubling dilution to add sample liquid, and the inhibition zone size is measured in 37 ℃ of cultivations behind the 24h-48h.Inhibition zone 10mm above as minimal inhibitory concentration (minimal inhibitory concentration, MIC).Bacterial isolates derives from institute of microbiology of Yunnan University, this experiment do three parallel, get geometrical mean, result such as table 2.
Table 2. hornet anti-bacterial peptide suppresses the effect of fungal growth
Figure C20051001066400052
Figure C20051001066400061
By table 2 as seen, the pure product of wasp venom and hornet anti-bacterial peptide all have the effect of significant inhibition fungal growth.
3. hornet anti-bacterial peptide suppresses the effect of growth of tumour cell
On the flat Tissue Culture Plate in 96 holes, testing sample is carried out 5 times or 2 times of doubling dilutions with perfect medium, totally 6 titres, 3 repetitions of each extent of dilution, every hole 100ul establishes the normal cell contrast simultaneously.Every hole drips 3 * 10 5The HeP3B cell of/ml or Molt-4 cell 100ul put 37 ℃, 5%CO 2Cultivate in the incubator.Use the toxic action of mtt assay working sample pair cell behind the 48h.EC50 is the drug level when 50% cell is produced cytotoxicity.The results are shown in Table 3.
The most of antibiotic medicine that is used does not clinically at present have function of tumor inhibition, and as seen from Table 3, wasp venom and hornet anti-bacterial peptide all have the effect of external significant inhibition growth of tumour cell.
Table 3. hornet anti-bacterial peptide suppresses the effect of growth of tumour cell
Figure C20051001066400062
4. hornet anti-bacterial peptide suppresses the effect of HIV-1 breeding
JC53-BL cell in the cell bottle is linked into aseptic 96 orifice plates with the concentration in 20000 in every hole, in the sDMEM substratum 37 ℃, cultivate 18h under the 5%CO2 condition, insert ultimate density and be 0.1,1.25,2.5,5,10, the sun product of 20ug/ml, similarity condition inserts the HIV-1 LAI strain and the BAL strain (MOI:0.009-0.65) of diluting with the sDMEM that contains 40ug EAE-dextran respectively and makes every Kongzui be 200ul eventually after cultivating 3h, put 37 ℃, 5%CO 2Calculate the inhibition concentration IC that suppresses percentage and 50% with the blue spot of X-Gal dyeing number after cultivating 48h in the incubator 50, blank is established in experiment, and positive control agent and add peptide and do not connect the contrast of poison is done four times and is repeated to ask geometric mean.
Table 4. hornet anti-bacterial peptide suppresses the effect of HIV-1 breeding
Figure C20051001066400071
By table 4 as seen, the pure product of wasp venom and hornet anti-bacterial peptide all have significant inhibition HIV-1 breeding effect.
Wasp venom and hornet anti-bacterial peptide all have the significant effect that suppresses bacterium, fungi and viral growth, all microbial bacteria/strains comprise: the LAI strain of intestinal bacteria, streptococcus aureus, Pseudomonas aeruginosa, streptococcus pneumoniae, bacillus megaterium, Bacillus subtilus, Candida albicans, flavus, mould, Mucor pusillus, cereuisiae fermentum, HIV-1 and BAL strain etc., the result shows that hornet anti-bacterial peptide has broad-spectrum anti-microbial activity and (comprises gram-negative, positive bacteria, fungi and virus, MIC and IC 50Respectively in the scope of 3.5-25ug/ml and 7ug/ml-15ug/ml).Hornet anti-bacterial peptide has the effect of significant inhibition growth of tumour cell simultaneously, hornet anti-bacterial peptide is respectively 3.1ug/m to the EC50 value of HeP3B cell and Molt-4 cell inhibiting rate, 20.7ug/ml, have active other of tumour cell inhibition in the time of with bibliographical information and come derived antimicrobial peptide to compare, the tumour cell of hornet anti-bacterial peptide suppresses active high 10-15 doubly.Therefore, hornet anti-bacterial peptide of the present invention be a kind of from distinct Chinese characteristics medicinal organism resource, develop first have antimicrobial, the polypeptide of tumor promotion.
Description of drawings:
Fig. 1 is the Sephadex G-50 gel filtration chromatography figure of hornet anti-bacterial peptide of the present invention.
Fig. 2 is the CM Sephadex C-25 cation exchange column chromatography figure of hornet anti-bacterial peptide of the present invention.
Fig. 3 is the anti-phase high pressure liquid chromatography figure of hornet anti-bacterial peptide of the present invention.
Fig. 4 is the flight time mass spectrum figure of hornet anti-bacterial peptide of the present invention.
Embodiment:
Further specify essentiality content of the present invention below in conjunction with accompanying drawing with embodiment, but content of the present invention is not limited thereto.
1, preparation hornet anti-bacterial peptide
The bee venom that the electricity irritation wasp is collected is centrifugal, and (10000rpm 10min) removes precipitation, cryopreservation after the lyophilize.
The first step, Sephadex G-50 gel filtration chromatography, the starting material wasp that obtains as stated above poison lyophilized powder 300mg is dissolved in the 5ml pure water, and 4 ℃ of centrifugal 10min of 10000rpm remove precipitation.SephadexG-50 gel-filtration column (long 1000mm, diameter 26mm) is used 0.1M Na 2HPO 4-NaH 2PO 4PH 6.0 damping fluid balances, fully after with on the sample in this post.Use same buffer solution elution, collect the III peak.
In second step, ion-exchange chromatography: the activeconstituents peak III that gel filtration chromatography obtains is splined on 0.1MNa 2HPO 4-NaH 2PO 4The abundant equilibrated CM of pH 6.0 damping fluids Sephadex C-25 cationic exchange coloum, exchange column length 300mm, diameter 26mm is washed till through two same damping fluids of half column volume and penetrates the peak by wash-out fully, with the 0.1M Na that contains Nacl 2HPO 4-NaH 2PO 4PH 6.0 buffer solution for gradient elution are collected the V peak;
The 3rd step, anti-phase high pressure liquid chromatography is: the activeconstituents peak V that ion-exchange chromatography obtains is splined on through the gradient elution of the abundant equilibrated C18 of the ultrapure water that contains 1 ‰ trifluoroacetic acids reversed-phase column (long 300mm, diameter 5mm) with the fine damping fluid of second from 15% to 65% that contains 1 ‰ trifluoroacetic acids.Collection time is the peak (second largest elution samples peak among the figure) at 45.4min place.
2. (Flight of time massspectrometry, TOF-MS), iso-electric point adopts isoelectrofocusing to measure to the hornet anti-bacterial peptide molecular weight determination of purifying employing flight time mass spectrum, measures the aminoacid sequence structure with automatic determined amino acid sequence instrument.
Hornet anti-bacterial peptide by method for preparing is that we separate a kind of single chain polypeptide that obtains first from Chinese segmental appendage class animal wasp venom, molecular weight 1316.6 dalton, iso-electric point 8.59, the polypeptide total order is classified as: Isoleucine-aspartic acid-tryptophane-LYS-GLY-Isoleucine-Ala-Ala-methionine(Met)-L-Ala-Methionin-Isoleucine (NH 2-IDWKGIAAMAKI-COOH).
Experimental result shows, hornet anti-bacterial peptide has the strong activity inhibition of bacterium, fungi, virus and growth of tumour cell, and have advantages such as no hemolytic activity, clotting of plasma activity, can be used as the application of preparation cause pathogeny imcrobe infection treatment of diseases medicine and anti-tumor medicine.

Claims (3)

1. hornet anti-bacterial peptide, it is characterized in that this antibacterial peptide is to separate a kind of single chain polypeptide that obtains from wasp, molecular weight 1316.6 dalton, iso-electric point 8.59, the polypeptide total order is classified as: Isoleucine-aspartic acid-tryptophane-LYS-GLY-Isoleucine-Ala-Ala-methionine(Met)-L-Ala-Methionin-Isoleucine.
2. the preparation method of the said hornet anti-bacterial peptide of claim 1 is characterized in that method comprises the centrifugal removal precipitation of bee venom that the electricity irritation wasp is collected, and lyophilize is after gel filtration chromatography, ion-exchange chromatography and anti-phase high pressure liquid chromatography separation and purification; Wherein:
2.1 gel filtration chromatography is: be splined on Sephadex G-50 gel-filtration column after the wasp venom lyophilized powder of collecting is dissolved in pure water, gel-filtration column length 1000mm, diameter 26mm uses 0.1M Na 2HPO 4-NaH 2PO 4PH 6.0 buffer solution elution are collected the III peak;
2.2 ion-exchange chromatography is: the activeconstituents peak III that gel filtration chromatography obtains is splined on 0.1MNa 2HPO 4-NaH 2PO 4PH 6.0 damping fluid equilibrated CM Sephadex C-25 cationic exchange coloums, exchange column length 300mm, diameter 26mm is with the 0.1M Na that contains Nacl 2HPO 4-NaH 2PO 4PH 6.0 buffer solution for gradient elution are collected the V peak;
2.3 anti-phase high pressure liquid chromatography is: the activeconstituents peak V that ion-exchange chromatography obtains is splined on through containing the ultrapure water equilibrated C18 reversed-phase column of 1 ‰ trifluoroacetic acids, column length 300mm, diameter 5mm, with the gradient elution of the fine damping fluid of the second that contains 1 ‰ trifluoroacetic acids from 15% to 65%, collection time is 45.4 minutes peaks of locating.
3. the application of the said hornet anti-bacterial peptide of claim 1 is characterized in that hornet anti-bacterial peptide is used to prepare the medicine of treatment cause pathogeny imcrobe infection disease and the medicine of treatment tumour.
CNB2005100106647A 2005-02-23 2005-02-23 Wasp antibiotic peptide and preparing method and use thereof Expired - Fee Related CN100475840C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100106647A CN100475840C (en) 2005-02-23 2005-02-23 Wasp antibiotic peptide and preparing method and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100106647A CN100475840C (en) 2005-02-23 2005-02-23 Wasp antibiotic peptide and preparing method and use thereof

Publications (2)

Publication Number Publication Date
CN1683399A CN1683399A (en) 2005-10-19
CN100475840C true CN100475840C (en) 2009-04-08

Family

ID=35262921

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100106647A Expired - Fee Related CN100475840C (en) 2005-02-23 2005-02-23 Wasp antibiotic peptide and preparing method and use thereof

Country Status (1)

Country Link
CN (1) CN100475840C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142995A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of esophageal cancer
CN103142994A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of leukemia
CN103142993A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of liver cancer

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102924574B (en) * 2012-10-26 2013-12-04 苏州康尔生物医药有限公司 Antibacterial peptide LZ1 and application of antibacterial peptide in preparation of antibacterial medicament
CN103275190B (en) * 2013-06-14 2014-10-15 四川合泰新光生物科技有限公司 Small molecular polypeptide ZY13 and application thereof
CN103638064A (en) * 2013-12-25 2014-03-19 大理学院 Analgesic and anti-inflammatory active site of Vespula insect, as well as preparation method and application thereof
CN110627891B (en) * 2019-10-12 2023-04-28 严家定 Method for concealing hemolytic toxic and side effects of bee venom hemolytic peptide
CN111116715A (en) * 2020-01-10 2020-05-08 大理大学 Wasp peptide WVD-I and preparation method and application thereof
CN111196840A (en) * 2020-01-10 2020-05-26 大理大学 Vespa mandarinia peptide WVC-I and preparation method and application thereof
CN112961218B (en) * 2021-03-29 2022-10-14 中国科学院西双版纳热带植物园 Peptide with broad-spectrum bactericidal activity and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106844A (en) * 1996-03-11 2000-08-22 The Rockfeller University Immunomodulatory peptides of vespid antigen 5

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106844A (en) * 1996-03-11 2000-08-22 The Rockfeller University Immunomodulatory peptides of vespid antigen 5

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142995A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of esophageal cancer
CN103142994A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of leukemia
CN103142993A (en) * 2013-03-04 2013-06-12 浙江理工大学 Application of Anoplin in treatment of liver cancer
CN103142995B (en) * 2013-03-04 2014-11-12 浙江理工大学 Application of Anoplin in treatment of esophageal cancer
CN103142994B (en) * 2013-03-04 2014-12-10 浙江理工大学 Application of Anoplin in treatment of leukemia
CN103142993B (en) * 2013-03-04 2014-12-10 浙江理工大学 Application of Anoplin in treatment of liver cancer

Also Published As

Publication number Publication date
CN1683399A (en) 2005-10-19

Similar Documents

Publication Publication Date Title
CN100475840C (en) Wasp antibiotic peptide and preparing method and use thereof
CN105087732B (en) A kind of rhizoma Gastrodiae polypeptide and preparation method and the medical application in anti-bacteria and anti-virus
CN103665111B (en) Variant HC-15 of a kind of chittue antibacterial peptide Hc-CATH and its preparation method and application
CN102924574B (en) Antibacterial peptide LZ1 and application of antibacterial peptide in preparation of antibacterial medicament
WO2019169873A1 (en) Nano antibacterial gel for treating wound infection and promoting healing and preparation method therefor
CN100522993C (en) Odorranagrahami antimicrobialpeptides and application thereof
CN104592360A (en) Alkaline antibacterial peptide as well as targeting design and application thereof
CN101020715B (en) Process of extracting and preparing deer nerve growth factor (DEER NGF)
CN102807610A (en) Antibacterial peptides and application of antibacterial peptides to preparation of medicament resisting drug-resistant bacteria
CN104163861B (en) Reptile antibacterial peptide Alligatorin5 and applications thereof
CN100547000C (en) A kind of hornet anti-bacterial peptide and its production and application
CN111518187B (en) Antibacterial peptide DN6NH2 and application thereof
CN104478996A (en) New cationic antimicrobial peptide and application thereof
KR101156082B1 (en) Composition for treating bovine mastitis
CN100575359C (en) A kind of Odorranagrahami antimicrobialpeptideand and uses thereof
CN114940701B (en) Targeting antifungal peptide LI and preparation method and application thereof
CN102516382B (en) Antimicrobial peptide Hainanenin-5 of Amolops hainanensis, gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis, and application of gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis
CN110354078B (en) Anti-candida albicans composition containing nisin and preparation method thereof
CN112724198A (en) Methicillin-resistant staphylococcus aureus-resistant antibacterial peptide and preparation method and application thereof
CN1161377C (en) Giant web bombinator skin peptide and its prepn. and pharmaceutical application
CN107216369A (en) Similar active peptide of a kind of nucleoprotamine and preparation method and application
CN103172721B (en) Amolops hainanensis antimicrobial peptide Hainanenin-1, and gene, separation purification, chemical synthesis and application thereof
CN109420164B (en) Amoxicillin and bromelain composition as well as preparation method and application thereof
CN109678944A (en) A kind of antibacterial polypeptide HF-18 and its preparation method and application
US9802982B2 (en) Peptide and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090408

Termination date: 20100223